Happy to hear role of immunisation and strategies to cover 20 - 30 percent of children not completing doses as put forward by @brucekirenga.
@VMusiime calls for multisectoral collaboration and Advocacy plans to fast track introduction of PCV-23.
@DianaAtwine
Speaking at the #LSHSymposium25 Prof. Victor Musiime notes that while early lung damage from indoor smoke leads to lifelong respiratory illness, over 85% of Ugandan households still use harmful fuels exposing children to harmful indoor smoke. #MLIat10#MyAirMyHealth
🔥 Join me in congratulating Prof. @VMusiime upon this @NEJM
publication! 🎉 👏
👉 Second-Line Antiretroviral Therapy for Children Living with HIV in Africa | New England Journal of Medicine https://t.co/poQRrHs1BX
👀Interested in #SUPPORT? Make sure to follow us so you never miss an update!🗞️
We´re proud to be empowering the next generation of African scientists as they lead groundbreaking research on #HIV-related mortality in children after hospital discharge 🏥
🧪@EDCTP3#GlobalHealth
The PediCAP trial found that children recovering from severe #pneumonia could safely switch from injectable to oral antibiotics earlier, and come home from hospital sooner.
These new results were presented today at #ESCMIDGlobal#ECCMID2024. Congratulations to the PediCAP team!
- 4 days' total antibiotic treatment is generally enough
- shorter durations are as good as 8 days
*This means early discharge from hospital* (2/2) #ESCMIDGlobal2024
Victor Musiime on the results of the PediCAP trial (severe childhood CAP):
- Switching children to oral antibiotics when health improves is safe, working just as well as 5 days of injectable antibiotics
- Amoxicillin is affordable and readily available (1/2) #ESCMIDGlobal2024
Post-Doctoral Position Alert! @Makerere is seeking a candidate for the SUPPORT project, focusing on pediatric HIV prevention. The role offers a 24-month contract, competitive salary (€3,413.76/month), and a 3-month secondment in Madrid. https://t.co/pfkIxaqDM4